Early Development of Colonic Adenocarcinoma With Minimal Polyposis in a Young Child With Metastatic Hepatoblastoma and Germline APC Mutation

J Pediatr Hematol Oncol. 2021 Nov 1;43(8):e1191-e1193. doi: 10.1097/MPH.0000000000002209.

Abstract

Germline adenomatous polyposis coli (APC) gene mutation is a cancer-predisposing condition commonly presenting as familial adenomatous polyposis. We describe a patient first diagnosed at the age of 3 years with metastatic hepatoblastoma. With a positive family history, germline testing confirmed maternally inherited APC mutation (p.Thr899Ansfs*13). The patient was subsequently diagnosed at 8 years with colonic adenocarcinoma in the absence of macroscopic polyposis. Total colectomy with adjuvant chemotherapy was delivered and the patient remained disease-free for 5 years since the second diagnosis. This report demonstrates the importance of considering germline APC mutation in children with hepatoblastoma, who may benefit from the early institution of colonoscopic surveillance.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / etiology
  • Adenocarcinoma / pathology*
  • Adenocarcinoma / therapy
  • Adenomatous Polyposis Coli / etiology
  • Adenomatous Polyposis Coli / pathology*
  • Adenomatous Polyposis Coli / therapy
  • Adenomatous Polyposis Coli Protein / genetics*
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chemotherapy, Adjuvant
  • Child
  • Child, Preschool
  • Colectomy
  • Colonic Neoplasms / etiology
  • Colonic Neoplasms / pathology*
  • Colonic Neoplasms / therapy
  • Combined Modality Therapy
  • Female
  • Germ-Line Mutation*
  • Hepatoblastoma / genetics
  • Hepatoblastoma / pathology*
  • Hepatoblastoma / therapy
  • Humans
  • Liver Neoplasms / genetics
  • Liver Neoplasms / pathology*
  • Liver Neoplasms / therapy
  • Prognosis

Substances

  • APC protein, human
  • Adenomatous Polyposis Coli Protein